Skip to content
Clinical Trials – home

Chloroprocaine Hydrochloride: A Comprehensive Guide for Patients

2 / 4
trials open to patients / all trials
2+
Countries

In short

Chloroprocaine Hydrochloride is a local anesthetic drug being studied in various clinical trials for its potential benefits in anesthesia and pain management. These trials are investigating its use in different medical procedures, including spinal anesthesia, epidural anesthesia, and topical anesthesia. Researchers are comparing Chloroprocaine to other anesthetics to evaluate its efficacy, onset time, duration of action, and safety profile.

At a glance

Primary uses in trials
Spinal anesthesia, epidural anesthesia, topical anesthesia
Types of procedures
Lower limb surgeries, cervical cerclage, cataract surgery, labor analgesia, axillary nerve blocks
Comparison drugs
Bupivacaine, lidocaine, ropivacaine, tetracaine
Key outcomes measured
Onset time, duration of action, efficacy, safety profile, time to motor block resolution
Potential advantages
Faster onset, shorter duration, quicker recovery, earlier patient discharge
Safety considerations
Monitoring for neurological complications, transient neurological symptoms, changes in vital signs
Administration routes
Intrathecal, epidural, topical (eye drops, intra-abdominal)

What is Chloroprocaine Hydrochloride?

Chloroprocaine hydrochloride, also known by brand names such as Nesacaine and Ampres, is a local anesthetic medication. It belongs to a class of drugs called ester-type local anesthetics. Chloroprocaine is derived from another anesthetic called procaine, but it has been modified to work faster and more effectively.

Medical Uses of Chloroprocaine

Chloroprocaine is used for various medical procedures that require local or regional anesthesia. Some of its common uses include:

  • Spinal anesthesia: Used for surgeries on the lower body, including cesarean sections and procedures on the legs
  • Epidural anesthesia: Used for pain relief during labor and delivery or for postoperative pain management in infants
  • Nerve blocks: Used to numb specific areas of the body, such as the arm for hand surgery
  • Eye surgery: Used as a topical anesthetic for cataract surgery

How Chloroprocaine Works

Chloroprocaine works by temporarily blocking nerve signals in the area where it's applied. This prevents pain signals from reaching the brain, resulting in numbness and loss of sensation in the affected area. The medication begins to work quickly, usually within 6 to 12 minutes after administration.

Once in the body, chloroprocaine is rapidly broken down by enzymes in the blood. This quick breakdown contributes to its short duration of action and low risk of toxicity.

How Chloroprocaine is Administered

Chloroprocaine can be administered in several ways, depending on the type of procedure:

  • Injection: For spinal or epidural anesthesia, it's injected into the space around the spinal cord
  • Nerve block: Injected near specific nerves to numb a particular area of the body
  • Topical application: Applied as eye drops or gel for eye surgeries

The dosage and concentration of chloroprocaine can vary depending on the specific procedure and the individual patient's needs.

Effectiveness of Chloroprocaine

Chloroprocaine is known for its rapid onset of action and short duration of effect. This makes it particularly useful for short procedures or when quick recovery is desired. Studies have shown that chloroprocaine can provide effective anesthesia for various procedures, including:

  • Short-duration lower limb surgeries
  • Cesarean sections
  • Labor analgesia
  • Cataract surgery

The quick wear-off time of chloroprocaine can lead to faster discharge from the recovery room after surgery, which is beneficial for both patients and hospitals.

Potential Side Effects

Like all medications, chloroprocaine can cause side effects. However, serious side effects are rare. Some potential side effects include:

  • Temporary decrease in blood pressure (occurs in about 1 in 100 patients)
  • Headache (occurs in about 1 in 100 patients)
  • Allergic reactions (very rare, occurs in about 1 in 100,000 patients)
  • Nerve damage (very rare, occurs in about 1 in 100,000 patients)

In some cases, the anesthetic effect may be inadequate, requiring additional medication or a switch to general anesthesia. This occurs in about 1 in 1,000 patients.

Comparisons with Other Anesthetics

Several studies have compared chloroprocaine to other local anesthetics:

  • Vs. Bupivacaine: Chloroprocaine was found to wear off faster than bupivacaine for spinal anesthesia in cesarean sections, potentially leading to quicker recovery.
  • Vs. Lidocaine: For epidural anesthesia, chloroprocaine was found to have a more rapid onset and shorter duration than lidocaine.
  • Vs. Ropivacaine: Studies are ongoing to compare the effectiveness of chloroprocaine and ropivacaine for nerve blocks and labor analgesia.

Ongoing Research

Research on chloroprocaine is ongoing to further understand its uses and effectiveness. Current studies are investigating:

  • The optimal dose of chloroprocaine for various procedures
  • The use of chloroprocaine for labor analgesia
  • The effectiveness of chloroprocaine gel for eye surgeries
  • The use of chloroprocaine for postoperative pain management in infants

These ongoing studies aim to provide more information about the safety and efficacy of chloroprocaine in various medical settings, potentially expanding its uses in the future.

Questions people often ask

Conditions where Chloroprocaine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Chloroprocaine Hydrochloride

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
  • Participants:Children
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).